Literature DB >> 12659978

The influence of age on gender-specific differences in the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy.

Pawel Petkow Dimitrow1, Danuta Czarnecka, Kalina Kawecka-Jaszcz, Jacek S Dubiel.   

Abstract

BACKGROUND: The aim of the study was to assess gender-specific differences in left ventricular cavity size, contractility and left ventricular outflow tract obstruction in younger and older subgroups of patients with hypertrophic cardiomyopathy.
METHODS: We studied retrospectively 153 referred patients with hypertrophic cardiomyopathy (89 males and 64 females). The echocardiographically measured left ventricular end-systolic, end-diastolic dimensions, fractional shortening and occurrence of left ventricular outflow tract gradient were compared between sexes in subgroups of patients </=50 and >50 years of age.
RESULTS: In younger patients with hypertrophic cardiomyopathy, left ventricular end-diastolic and end-systolic dimensions were significantly smaller in females than males (41.9+/-5.8 vs. 44.7+/-5 mm P<0.01 23.4+/-5 vs. 25.2+/-5.4 mm P<0.05, respectively). Fractional shortening was comparable in both sexes (44.7+/-7.5 vs. 43.7+/-8.2% P>0.05). The left ventricular outflow tract gradient occurred in females as frequently as in males (13.3 vs. 17.6% P>0.05). In older patients with hypertrophic cardiomyopathy, left ventricular end-diastolic and end-systolic dimensions were also significantly smaller in females than males (42.5+/-6 vs. 46.3+/-3.2 mm P<0.02; 25.7+/-4.8 vs. 28.6+/-3.7 mm P<0.01, respectively). In contrast to the younger group, the fractional shortening was significantly higher in females than males (44.4+/-6.8 vs. 38.2+/-7.3% P<0.02). The left ventricular outflow tract gradient occurred in females more frequently than in males (63.2 vs. 20.8% P<0.02).
CONCLUSIONS: In patients with hypertrophic cardiomyopathy, the gender-based differences in the absolute value of left ventricular cavity size persisted with aging. In older females left ventricular contractility was higher and left ventricular outflow tract gradient occurred more frequently than in males. In younger patients with hypertophic cardiomyopathy these sex-based differences were absent. The gender-specific differences in the parameters of left ventricular systolic function became apparent with increasing age.

Entities:  

Mesh:

Year:  2003        PMID: 12659978     DOI: 10.1016/s0167-5273(02)00323-6

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice.

Authors:  Camille L Birch; Samantha M Behunin; Marissa A Lopez-Pier; Christiane Danilo; Yulia Lipovka; Chandra Saripalli; Henk Granzier; John P Konhilas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

Review 2.  What we know and do not know about sex and cardiac disease.

Authors:  John P Konhilas
Journal:  J Biomed Biotechnol       Date:  2010-04-22

3.  Relationship between sex, shape, and substrate in hypertrophic cardiomyopathy.

Authors:  J Martijn Bos; Jeanne L Theis; A Jamil Tajik; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Journal:  Am Heart J       Date:  2008-02-21       Impact factor: 4.749

Review 4.  Obstructive Form of Hypertrophic Cardiomyopathy-Left Ventricular Outflow Tract Gradient: Novel Methods of Provocation, Monitoring of Biomarkers, and Recent Advances in the Treatment.

Authors:  Pawel Petkow Dimitrow; Renata Rajtar-Salwa
Journal:  Biomed Res Int       Date:  2016-05-10       Impact factor: 3.411

5.  Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014.

Authors:  Renata Rajtar-Salwa; Rafał Hładij; Paweł Petkow Dimitrow
Journal:  Dis Markers       Date:  2017-11-20       Impact factor: 3.434

6.  Sex differences in the prognosis of patients with hypertrophic cardiomyopathy.

Authors:  Minkwan Kim; Bongsung Kim; You-Jung Choi; Hyun-Jung Lee; Heesun Lee; Jun-Bean Park; Seung-Pyo Lee; Kyung-Do Han; Yong-Jin Kim; Hyung-Kwan Kim
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

7.  Gender Related Differences in the Clinical Presentation of Hypertrophic Cardiomyopathy-An Analysis from the SILICOFCM Database.

Authors:  Andrej Preveden; Miodrag Golubovic; Marija Bjelobrk; Tatjana Miljkovic; Aleksandra Ilic; Snezana Stojsic; Dragan Gajic; Mila Glavaski; Lars S Maier; Nduka Okwose; Dejana Popovic; Fausto Barlocco; Arsen Ristic; Guy A MacGowan; Iacopo Olivotto; Nenad Filipovic; Djordje G Jakovljevic; Lazar Velicki
Journal:  Medicina (Kaunas)       Date:  2022-02-18       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.